As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, ...

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Kim White's battle with adrenocortical carcinoma highlights her resilience and determination to live life fully despite her ...

When my daughter was diagnosed with breast cancer, writing our truth helped me and others face the harsh realities and ...

Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

Emerging treatments like rusfertide may reduce phlebotomies and improve life for patients with polycythemia vera, according ...